Announcement
·
06 May 2025
·
M42 appoints Dimitris Moulavasilis as Group CEO

About M42

M42 is a global health champion powered by artificial intelligence (AI), technology and genomics to advance innovation in health for people and the planet. Headquartered in Abu Dhabi, M42 combines its specialized, state-of-the-art facilities with integrated health solutions like genomics and biobanks, and harnesses advanced technologies to deliver precise, preventive and predictive care, to impactfully disrupt traditional healthcare models and positively impact lives globally.

Established in 2022, following the coming together of G42 Healthcare and Mubadala Health, M42 has more than 480 facilities in 26 countries and over 20,000 employees. M42 includes renowned healthcare providers including Cleveland Clinic Abu Dhabi, Danat Al Emarat, Diaverum, Imperial College London Diabetes Centre, Sheikh Sultan bin Zayed Hospital, and Moorfields Eye Hospital Abu Dhabi. As well as operating the Emirati Genome Programme, M42 runs Abu Dhabi BioBank and Abu Dhabi Health Data Services (ADHDS), a global tech-enabled healthcare company operating Malaffi.

Mission

To deliver world-class patient-centric care enabled by advanced technologies and innovative solutions.

Vision

To transform lives through innovation.

Values

Innovation
Excellence
Partnership
Integrity
Compassion

Code of Ethics

The M42 Code of Ethics charts our path to achieving our mission through ethical excellence and unwavering integrity.

M42 Code of Ethics

Learn More

M42 Business Partner Code of Conduct

Learn More

Report any questions or concerns:

ethics@m42.ae +971 2 3111 333